This week in optometry: November 20-November 24

News
Article

Catch up on what happened in optometry during the week of November 20-November 24.

Catch up with what Optometry Times®' shared this week:

Clinical characteristics and progression of geographic atrophy in a Japanese population

Lynda Charters

A multicenter study in Japan examined patients to understand geographic atrophy characteristics and progression rate.

Learn more...

LENZ Therapeutics, Graphite Bio enter merger agreement

David Hutton, Managing Editor, Ophthalmology Times

According to the companies, the merger creates a NASDAQ-listed, late clinical-stage biopharmaceutical company focused on advancing LENZ Therapeutics’ lead assets for the treatment of presbyopia.

Read more...

Why Not You Foundation and CommonSpirit Health donate $100,000 grant to EyeCare4Kids

Marlisa Miller, Editorial Intern

EyeCare4Kids was chosen as a recipient of a $100,000 grant from Russell Wilson, Denver Broncos quarterback, and his wife Ciara, talented singer-songwriter, in a partnership with CommonSpirit Health. The donation is a part of their commitment to contribute $1 million to 10 charitable organizations in Utah and Colorado from the couple’s Why Not You Foundation. EyeCare4Kids plans to use this award from the 2023 CommonSpirit Equity Fund to provide professional eye care services and eyeglasses to low-income, visually impaired children across the state of Utah.


Continue reading...

Retraining the brain to tackle visual snow syndrome with mindfulness-based cognitive therapy

Lynda Charters

The investigators use mindfulness-based cognitive therapy (MBCT) on patients who have never previously practiced the technique, with the aim of possibly re-training their brains to remove their static-type images.

Learn more...

Separating the business of optometry from the desire to help patients

Benjamin P. Casella, OD, FAAO

Dr Ben Casella ruminates on accepting certain forms of insurance and choosing what is right for your patient population.

Read more...

EyeCon 2023: Pearls for monitoring intraocular pressure at home and in the office

Thomas V. Johnson, MD, PhD; Stevenson, Eye Care Group Editorial Director

This December, Optometry Times' EyeCon 2023 will gather the nation’s leading optometrists and ophthalmologists to share new data and practical strategies that clinicians can apply to their patients. Thomas V. Johnson, MD, PhD, who is part of the faculty for EyeCon 2023, recently spoke with Sheryl Stevenson, Eye Care Group editorial director, to highlight his presentation.

Watch now...

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.